elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabryho choroba - iné alimentárny trakt a metabolizmus výrobky, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
abisax 20 mg
glenmark pharmaceuticals s.r.o., Česká republika - bilastín - 24 - antihistaminica, histamin
iberogast neo
bayer, spol. s r.o., slovensko - lieČivÁ na funkČnÉ gastrointestinÁlne poruchy - 94 - fytopharmaca